# clm_4E462623C749

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: operating_income  
value: 58,644,000,000 DKK  
valid_from: 2021-12-31  
valid_to: 2022-12-31  
published: 2022-02-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F3418E0D3161  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk operating income: 58,644,000,000 DKK", as of 2021-12-31 (until 2022-12-31). Claim clm_4E462623C749, https://asof.is/claim/clm_4E462623C749, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2021, filed 2022-02-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm (primary, SEC EDGAR 20-F FY2021, published 2022-02-02)

## Supersedes

- [Novo Nordisk](/record/novo-nordisk.md) | operating_income | 54,126,000,000 DKK | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_4E462623C749](/claim/clm_4E462623C749.md) | [clm_D272A9AE2D76](/claim/clm_D272A9AE2D76.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.